Nasal Congestion Management

Introduction to Treatment Options

The American Academy of Otolaryngology-Head and Neck Surgery recommends intranasal corticosteroids as first-line therapy for moderate-to-severe congestion, which can be used in combination with short-term oxymetazoline (≤3 days) for severe nasal obstruction, with a 3-day limit for oxymetazoline nasal spray use to prevent rhinitis medicamentosa 1
Oral antihistamine-decongestant combinations are suggested as an alternative if nasal sprays are not tolerated, and are more effective than either component alone, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

Decongestants, such as pseudoephedrine, should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, glaucoma, or bladder neck obstruction, due to their potential to exacerbate these conditions, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Second-generation antihistamines are preferred over first-generation antihistamines for treatment of rhinitis, due to their improved efficacy and safety profile, and can be used in combination with decongestants for allergic components, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Oral decongestants can cause systemic effects, including elevated blood pressure, palpitations, and sleep disturbance, especially in patients with hypertension, cardiovascular disease, hyperthyroidism, glaucoma, or bladder neck obstruction, and should be monitored closely, as recommended by the American Heart Association and the American Academy of Allergy, Asthma, and Immunology 2

The American Geriatrics Society recommends using decongestants with caution in the elderly due to increased risk of adverse effects 2
The American Academy of Pediatrics recommends avoiding oral decongestants in children under 6 years due to the risk of agitated psychosis, ataxia, hallucinations, and death (in rare cases), and suggests saline nasal irrigation as a first-line treatment for infants under 2-6 months who are obligate nasal breathers 2

Buffered hypertonic (3%-5%) saline may have a superior anti-inflammatory effect and improves quality of life and decreases medication use, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 3
Saline nasal irrigation followed by gentle aspiration is a safe and effective adjunctive therapy for long-term use, helping to thin secretions and remove allergens/irritants, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2, 3, 1, 4

For intranasal corticosteroids, monitor growth in children using long-term therapy, and limit use to 2 months per year in children 4-11 years and 6 months in adults before physician review, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Topical decongestants should be strictly limited to 3 days to prevent rhinitis medicamentosa, and development of rhinitis medicamentosa is highly variable, and may develop within 3 days of use, making patient education and monitoring crucial 2